Home > Financial Ratios > BROOKS LABORATORIES

BROOKS LABORATORIES
Core EBITDA Margin

    Back to All Ratios
COMMUNITY POLL
for BROOKS LABORATORIES
Please provide your vote to see the results

BROOKS LABORATORIES Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Margin(%) 8.231.623.86-41.80-15.63

What is the latest Core EBITDA Margin ratio of BROOKS LABORATORIES ?

The latest Core EBITDA Margin ratio of BROOKS LABORATORIES is 8.23 based on Mar2026 Consolidated results.
Year Core EBITDA Margin
Mar20268.23
Mar20251.62
Mar20243.86
Mar2023-41.80
Mar2022-15.63

How is Core EBITDA Margin of BROOKS LABORATORIES Trending?

Years Core EBITDA Margin % Change
Mar2026 8.23
408.02
Mar2025 1.62
-58.03
Mar2024 3.86
Positive
Mar2023 -41.8
Negative
Mar2022 -15.63 -

Other Financial Ratios of BROOKS LABORATORIES


Compare Core EBITDA Margin ratio of peers of BROOKS LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BROOKS LABORATORIES ₹162.8 Cr -6.4% -17.6% -61% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹434,280.0 Cr -2.4% -6.2% 11.8% Stock Analytics
DIVIS LABORATORIES ₹246,737.0 Cr -3.3% 1.4% 57.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹181,129.0 Cr -4.5% -4% 35.9% Stock Analytics
CIPLA ₹108,808.0 Cr -3.6% -5% -10.6% Stock Analytics
DR REDDYS LABORATORIES ₹100,170.0 Cr -0.2% 2.5% -3% Stock Analytics


BROOKS LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BROOKS LABORATORIES

-6.4%

-17.6%

-61%

SENSEX

-2.3%

-6.6%

-12%


You may also like the below Video Courses